IL173204A0 - Novel cyanopyrrolidides, methods for the production thereof, and use of the same as medicaments - Google Patents
Novel cyanopyrrolidides, methods for the production thereof, and use of the same as medicamentsInfo
- Publication number
- IL173204A0 IL173204A0 IL173204A IL17320406A IL173204A0 IL 173204 A0 IL173204 A0 IL 173204A0 IL 173204 A IL173204 A IL 173204A IL 17320406 A IL17320406 A IL 17320406A IL 173204 A0 IL173204 A0 IL 173204A0
- Authority
- IL
- Israel
- Prior art keywords
- cyanopyrrolidides
- medicaments
- novel
- production
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10333935A DE10333935A1 (en) | 2003-07-25 | 2003-07-25 | New bicyclic cyano-heterocycles, process for their preparation and their use as pharmaceuticals |
DE102004019276A DE102004019276A1 (en) | 2004-04-21 | 2004-04-21 | New cyanopyrrolizine derivatives, used e.g. for lowering blood sugar, treating type 2 diabetes, treating disorders of lipid and carbohydrate metabolism, treating arteriosclerotic symptoms |
PCT/EP2004/007761 WO2005012308A1 (en) | 2003-07-25 | 2004-07-14 | Novel cyanopyrrolidides, methods for the production thereof, and use of the same as medicaments |
Publications (1)
Publication Number | Publication Date |
---|---|
IL173204A0 true IL173204A0 (en) | 2006-06-11 |
Family
ID=34117368
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL173204A IL173204A0 (en) | 2003-07-25 | 2006-01-17 | Novel cyanopyrrolidides, methods for the production thereof, and use of the same as medicaments |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1651649B1 (en) |
JP (1) | JP2006528601A (en) |
AR (1) | AR045080A1 (en) |
AT (1) | ATE490256T1 (en) |
AU (1) | AU2004261364A1 (en) |
BR (1) | BRPI0412900A (en) |
CA (1) | CA2534267A1 (en) |
DE (1) | DE502004011957D1 (en) |
IL (1) | IL173204A0 (en) |
MX (1) | MXPA06000634A (en) |
PE (1) | PE20050249A1 (en) |
TW (1) | TW200524936A (en) |
WO (1) | WO2005012308A1 (en) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DOP2006000008A (en) | 2005-01-10 | 2006-08-31 | Arena Pharm Inc | COMBINED THERAPY FOR THE TREATMENT OF DIABETES AND RELATED AFFECTIONS AND FOR THE TREATMENT OF AFFECTIONS THAT IMPROVE THROUGH AN INCREASE IN THE BLOOD CONCENTRATION OF GLP-1 |
GB0526291D0 (en) | 2005-12-23 | 2006-02-01 | Prosidion Ltd | Therapeutic method |
PE20071221A1 (en) | 2006-04-11 | 2007-12-14 | Arena Pharm Inc | GPR119 RECEPTOR AGONISTS IN METHODS TO INCREASE BONE MASS AND TO TREAT OSTEOPOROSIS AND OTHER CONDITIONS CHARACTERIZED BY LOW BONE MASS, AND COMBINED THERAPY RELATED TO THESE AGONISTS |
RU2009108280A (en) | 2006-08-08 | 2010-09-20 | Санофи-Авентис (Fr) | Arylamino-arylalkyl-substituted imidazolidine-2,4-dione, methods for their preparation containing these compounds and their use |
DE102007005045B4 (en) | 2007-01-26 | 2008-12-18 | Sanofi-Aventis | Phenothiazine derivatives, process for their preparation and their use as medicines |
EP2025674A1 (en) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituted tetra hydro naphthalines, method for their manufacture and their use as drugs |
EP2146210A1 (en) | 2008-04-07 | 2010-01-20 | Arena Pharmaceuticals, Inc. | Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditions modulated by PYY |
WO2010003624A2 (en) | 2008-07-09 | 2010-01-14 | Sanofi-Aventis | Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
AR077642A1 (en) | 2009-07-09 | 2011-09-14 | Arena Pharm Inc | METABOLISM MODULATORS AND THE TREATMENT OF DISORDERS RELATED TO THE SAME |
WO2011023754A1 (en) | 2009-08-26 | 2011-03-03 | Sanofi-Aventis | Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use |
WO2011107494A1 (en) | 2010-03-03 | 2011-09-09 | Sanofi | Novel aromatic glycoside derivatives, medicaments containing said compounds, and the use thereof |
EP2556056A1 (en) | 2010-04-06 | 2013-02-13 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2011157827A1 (en) | 2010-06-18 | 2011-12-22 | Sanofi | Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases |
US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
SG188548A1 (en) | 2010-09-22 | 2013-04-30 | Arena Pharm Inc | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
EP2683701B1 (en) | 2011-03-08 | 2014-12-24 | Sanofi | Oxathiazine derivatives substituted with benzyl or heteromethylene groups, method for their preparation, their usage as medicament, medicament containing same and its use |
EP2683698B1 (en) | 2011-03-08 | 2017-10-04 | Sanofi | Benzyl-oxathiazine derivates substituted with adamantane or noradamantane, medicaments containing said compounds and use thereof |
WO2012120057A1 (en) | 2011-03-08 | 2012-09-13 | Sanofi | Novel substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof |
US8828995B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
WO2012120055A1 (en) | 2011-03-08 | 2012-09-13 | Sanofi | Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
EP2683700B1 (en) | 2011-03-08 | 2015-02-18 | Sanofi | Tetra-substituted oxathiazine derivatives, method for their preparation, their usage as medicament and medicament containing same and its use |
WO2012120052A1 (en) | 2011-03-08 | 2012-09-13 | Sanofi | Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof |
WO2012120054A1 (en) | 2011-03-08 | 2012-09-13 | Sanofi | Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
US8809324B2 (en) | 2011-03-08 | 2014-08-19 | Sanofi | Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof |
WO2012135570A1 (en) | 2011-04-01 | 2012-10-04 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
EA201391264A1 (en) | 2011-04-13 | 2014-03-31 | Джилид Сайэнс, Инк. | 1'-SUBSTITUTED PYRIMIDINE N-NUCLEOSIDE ANALOGUES FOR ANTI-VIRUS TREATMENT |
US20140066369A1 (en) | 2011-04-19 | 2014-03-06 | Arena Pharmaceuticals, Inc. | Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto |
US20140051714A1 (en) | 2011-04-22 | 2014-02-20 | Arena Pharmaceuticals, Inc. | Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto |
WO2012145603A1 (en) | 2011-04-22 | 2012-10-26 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2012170702A1 (en) | 2011-06-08 | 2012-12-13 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
EP2760862B1 (en) | 2011-09-27 | 2015-10-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
WO2013055910A1 (en) | 2011-10-12 | 2013-04-18 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
IN2015DN03795A (en) | 2012-10-24 | 2015-10-02 | Inserm Inst Nat De La Santé Et De La Rech Médicale | |
WO2014074668A1 (en) | 2012-11-08 | 2014-05-15 | Arena Pharmaceuticals, Inc. | Modulators of gpr119 and the treatment of disorders related thereto |
KR20180006881A (en) | 2015-03-09 | 2018-01-19 | 인테크린 테라퓨틱스, 아이엔씨. | Methods for the treatment of nonalcoholic fatty liver disease and / or fat dystrophy |
EP3273981B1 (en) | 2015-03-24 | 2020-04-29 | INSERM - Institut National de la Santé et de la Recherche Médicale | Method and pharmaceutical composition for use in the treatment of diabetes |
WO2018187350A1 (en) | 2017-04-03 | 2018-10-11 | Coherus Biosciences Inc. | PPARγ AGONIST FOR TREATMENT OF PROGRESSIVE SUPRANUCLEAR PALSY |
CN109867679B (en) * | 2019-04-11 | 2021-11-30 | 杭州瀚康生物医药科技有限公司 | Preparation method of piricaconide hydrochloride intermediate |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2997894B2 (en) * | 1990-11-07 | 2000-01-11 | 株式会社三和化学研究所 | Prevention and treatment of cardiovascular diseases |
WO1999031507A1 (en) * | 1997-12-18 | 1999-06-24 | Eli Lilly And Company | Peptidomimetic template-based combinatorial libraries |
-
2004
- 2004-07-13 PE PE2004000665A patent/PE20050249A1/en not_active Application Discontinuation
- 2004-07-14 AU AU2004261364A patent/AU2004261364A1/en not_active Abandoned
- 2004-07-14 DE DE502004011957T patent/DE502004011957D1/en active Active
- 2004-07-14 JP JP2006520734A patent/JP2006528601A/en not_active Abandoned
- 2004-07-14 BR BRPI0412900-8A patent/BRPI0412900A/en not_active IP Right Cessation
- 2004-07-14 CA CA002534267A patent/CA2534267A1/en not_active Abandoned
- 2004-07-14 EP EP04740981A patent/EP1651649B1/en not_active Not-in-force
- 2004-07-14 MX MXPA06000634A patent/MXPA06000634A/en not_active Application Discontinuation
- 2004-07-14 AT AT04740981T patent/ATE490256T1/en active
- 2004-07-14 WO PCT/EP2004/007761 patent/WO2005012308A1/en active Search and Examination
- 2004-07-22 TW TW093121832A patent/TW200524936A/en unknown
- 2004-07-22 AR ARP040102609A patent/AR045080A1/en unknown
-
2006
- 2006-01-17 IL IL173204A patent/IL173204A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2004261364A1 (en) | 2005-02-10 |
EP1651649B1 (en) | 2010-12-01 |
WO2005012308A1 (en) | 2005-02-10 |
ATE490256T1 (en) | 2010-12-15 |
AR045080A1 (en) | 2005-10-12 |
DE502004011957D1 (en) | 2011-01-13 |
PE20050249A1 (en) | 2005-06-01 |
BRPI0412900A (en) | 2006-10-31 |
TW200524936A (en) | 2005-08-01 |
JP2006528601A (en) | 2006-12-21 |
EP1651649A1 (en) | 2006-05-03 |
CA2534267A1 (en) | 2005-02-10 |
MXPA06000634A (en) | 2006-08-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL173204A0 (en) | Novel cyanopyrrolidides, methods for the production thereof, and use of the same as medicaments | |
EG25011A (en) | Amino-piperidin-1-yl-xanthines, the production thereof and the use of the same as medicaments. | |
PL378065A1 (en) | Substituted n-arylheterocycles, method for production and use thereof as medicaments | |
HK1100409A1 (en) | Substituted tetrahydro-2h-isoquinolin-1-one derivatives, method for the production thereof, and use of the same as medicaments | |
AU2003293757A1 (en) | Novel substituted imidazo-pyridinones and imidazo-pyridazeiones, the production and use thereof as medicaments | |
IL191926A0 (en) | Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof | |
AU2003282094A1 (en) | Novel dihydroxy-methylphenyl derivatives, method for the production and use thereof as medicaments | |
IL175245A0 (en) | Thiozolidinones, production and use thereof as medicaments | |
IL181012A0 (en) | Substituted 8-aminoalkoxi-xanthines, method for the production thereof and use thereof as medicaments | |
IL180874A0 (en) | Substituted, bicyclic 8-pyrrolidinoxanthines, method for the production thereof and their use as medicaments | |
PL375344A1 (en) | Novel carboxamide compounds having an mch-antagonistic effect, medicaments containing said compounds, and methods for the production thereof | |
AU2003292239A8 (en) | Novel carboxamides, the production and use thereof as medicaments | |
HUP0401293A3 (en) | Novel dihydropteridinones, method for producing the same and the use thereof as medicaments | |
PL1673352T3 (en) | Sulfoximine-substituted pyrimidines for use as cd and/or vegf-inhibitors, the production thereof and their use as drugs | |
HK1097734A1 (en) | 1-amino-2-oxy-substituted tetrahydronaphtalene derivatives, methods for the production thereof, and their use as antiphlogistics | |
HK1098737A1 (en) | Process for the preparation of 1,1,1,3,3-pentafluoro-2-chloropropene and 1,1,1,3,3,3-hexafluoro-2-chloropropane | |
IL179170A0 (en) | Novel substituted thiophenecarboxamides, their production and their use as medicaments | |
ZA200506422B (en) | Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use of the same as medicaments, and medicament containing such compounds | |
IL162669A0 (en) | Antichlinergic agents, method for producing the same and use thereof as medicaments | |
HK1089671A1 (en) | Novel imidazole derivatives, the production thereof, and the use of the same as a medicament | |
IL162316A0 (en) | Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition t | |
PL377741A1 (en) | Diarylcycloalkyl derivatives, method for their production and their use as medicaments | |
AU2003255612A8 (en) | Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments | |
IL174975A0 (en) | 2-phenyl-benzofuran derivatives, method for the production thereof and their use | |
ZA200601001B (en) | Substituted thienoimidazoles, method for production and use thereof as medicament or diagnostic and medicament comprising the same |